Journal de bord

Photobiomodulation therapy: the power of light

12 September 2019 | Press releases

Photobiomodulation could reduce some of the side effects of cancer treatments such as mucositis and dermatitis. Doctors have high hopes for this new therapy, although they are waiting for a proof of efficacy and tolerance. Moreover, photobiomodulation has a large potential, as this procedure is not limited to oncology. Photobiomodulation, a new therapy to treat […]

Read more

Maturation of Liquid Biopsy as a tool to optimize cancer treatment

1 August 2019 | Press releases

Alcimed, an innovation & new business consulting firm, has explored the trends in the liquid biopsy field and discusses some of the challenges as players move from the Non-invasive Prenatal Testing (NIPT) market toward further validation in oncology. Liquid biopsy’s first application was in non-invasive prenatal testing with an explosive market penetration. Liquid biopsy has […]

Read more

Interventional oncology, a new weapon against cancer

30 July 2019 | Press releases

As part of the demand for more personalized and less aggressive treatments, interventional oncology represents a major field of innovation for cancer treatment. While it makes it possible both to optimize the diagnosis and to expand the therapeutic arsenal, it faces obstacles in terms of funding and accessibility.  To mark the opening of a high-tech […]

Read more

Bioprinting, an upcoming revolution?

25 July 2019 | Press releases

In April, researchers at Tel Aviv University succeeded in recreating a vascularized heart through 3D printing. Even if the organ was the size of a cherry, the progress is immense, and research is getting closer to the ultimate goal of reconstructing organs. The field of bioprinting is booming as many applications are being developed. Alcimed, […]

Read more

The promises of blockchain: The law behind crypto-health!

12 July 2019 | Press releases

While the popularity of Bitcoin has gradually run out of steam, following the fall in its value, the general enthusiasm has now shifted to the technology that supported it: blockchain. The expectations fostered by this new way of transmitting information are such that blockchain is becoming an essential innovation theme in all sectors. Alcimed, a […]

Read more

A solution to the lack of effectiveness of treatments for neurodegenerative diseases: targeting inflammation!

9 July 2019 | Press releases

Due to the lack of certainty about their mechanism of action, research surrounding neurodegenerative diseases seems to be at an impasse. However, today, other therapeutic approaches are being considered, starting with neuroinflammation. Alcimed, an innovation and new business consulting firm, follows the advances of this research, which is opening up new treatment opportunities. While current […]

Read more

Digital, for easier and faster access to real life patient data

4 July 2019 | Press releases

The development of digital technologies offers the opportunity for pharmaceutical companies to think about doing things differently and better in many of their activities. ALCIMED, a consulting company in innovation and new businesses, analyses the opportunity offered by digital technology to acquire real-life patient data more easily and quickly. Real life data are generated as […]

Read more

Air taxis, a dream becoming reality!

27 June 2019 | Press releases

Air travel seems to be an increasingly feasible and promising solution to the major challenges of reducing congestion in overcrowded urban areas. The transition of urban transport to this third dimension raises many questions, particularly about regulatory aspects, societal acceptance, infrastructure deployment or the technological maturity of vehicles. But could we expect air taxis to […]

Read more

Vulvodynia: a little-known but highly impacting condition for many women around the world

18 June 2019 | Press releases

According to a study conducted by Alcimed, most patients with vulvodynia would consult about 10 different healthcare professionals over several years before receiving the correct diagnosis associated to these symptoms. Lyon, May 10, 2019 – The word vulvodynia comes from “vulvo” meaning vulva and “dyny” meaning pain, which literally means “pain in the vulva”. However, […]

Read more

The laboratory of the future

14 June 2019 | Press releases

In today’s digital revolution – Industry 4.0, Big Data, Human Machine Interface (HMI), and intelligent connectivity – working environments are changing completely. While certain industries have already profoundly changed their processes, certain sectors such as Research are still in its infancy. Great technological upheavals are emerging and could strongly impact the field of Research. Alcimed, […]

Read more

The Long Road for Oligonucleotide Therapeutics

7 June 2019 | Press releases

Alcimed, an innovation and new business consulting firm, highlights the race for oligonucleotide therapeutics to catch peptides and discusses the current limitations for its widespread therapeutic use. March 22, 2019. Peptide vs Oligonucleotides: Iterative vs Exploratory Innovation Over the last 30 years, peptide technologies have gone from the forefront of innovative biotech to a standard […]

Read more